Amyris advances to regulatory stage with another significant health & nutrition molecule

Amyris, inc. announced that it is moving into the regulatory stage with a new, undisclosed health and nutrition molecule. amyris has proven its capability to produce health and nutrition molecules at commercial scale with three others; artemisinin, vitamin e and, most recently, reb m. amyris developed a process for this ingredient that enables the highest purity at the lowest cost and has now successfully manufactured material via large scale fermentation. the company plans to submit formal regulatory filings for this ingredient (currently not being named due to partner's requirements) where required for rapid approval and market entry during the first half of 2020.
AMRS Ratings Summary
AMRS Quant Ranking